BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36498069)

  • 1. MRI-Derived Apparent Diffusion Coefficient of Peri-Prostatic Adipose Tissue Is a Potential Determinant of Prostate Cancer Aggressiveness in Preoperative Setting: A Preliminary Report.
    Tafuri A; Panunzio A; Greco F; Maglietta A; De Carlo F; Di Cosmo F; Luperto E; Rizzo M; Cavaliere A; De Mitri R; Zacheo F; Baviello M; Cimino A; Pisino M; Giordano L; Accettura C; Porcaro AB; Antonelli A; Cerruto MA; Ciurlia E; Leo S; Quarta LG; Pagliarulo V;
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36498069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T1 Mapping of the Prostate Using Single-Shot T1FLASH: A Clinical Feasibility Study to Optimize Prostate Cancer Assessment.
    Al-Bourini O; Seif Amir Hosseini A; Giganti F; Balz J; Heitz LG; Voit D; Lotz J; Trojan L; Frahm J; Uhlig A; Uhlig J
    Invest Radiol; 2023 Jun; 58(6):380-387. PubMed ID: 36729865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to implement magnetic resonance imaging before prostate biopsy in clinical practice: nomograms for saving biopsies.
    Borque-Fernando Á; Esteban LM; Celma A; Roche S; Planas J; Regis L; de Torres I; Semidey ME; Trilla E; Morote J
    World J Urol; 2020 Jun; 38(6):1481-1491. PubMed ID: 31506748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraductal carcinoma of the prostate (IDC-P) lowers apparent diffusion coefficient (ADC) values among intermediate risk prostate cancers.
    Currin S; Flood TA; Krishna S; Ansari A; McInnes MDF; Schieda N
    J Magn Reson Imaging; 2019 Jul; 50(1):279-287. PubMed ID: 30585372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI-measured periprostatic adipose tissue volume as a prognostic predictor in prostate cancer patients undergoing laparoscopic radical prostatectomy.
    Xiong T; Cao F; Zhu G; Ye X; Cui Y; Xing N; Zhang H; Niu Y
    Adipocyte; 2023 Dec; 12(1):2201964. PubMed ID: 37042512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI grading for the prediction of prostate cancer aggressiveness.
    Boschheidgen M; Schimmöller L; Arsov C; Ziayee F; Morawitz J; Valentin B; Radke KL; Giessing M; Esposito I; Albers P; Antoch G; Ullrich T
    Eur Radiol; 2022 Apr; 32(4):2351-2359. PubMed ID: 34748064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of T
    Klingebiel M; Schimmöller L; Weiland E; Franiel T; Jannusch K; Kirchner J; Hilbert T; Strecker R; Arsov C; Wittsack HJ; Albers P; Antoch G; Ullrich T
    J Magn Reson Imaging; 2022 Aug; 56(2):413-422. PubMed ID: 35038203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of multiparametric MRI features to identify the presence of prevalent cribriform pattern in the peripheral zone tumors.
    Gaudiano C; Bianchi L; De Cinque A; Corcioni B; Giunchi F; Schiavina R; Fiorentino M; Brunocilla E; Golfieri R
    Radiol Med; 2022 Feb; 127(2):174-182. PubMed ID: 34850354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The performance of intravoxel-incoherent motion diffusion-weighted imaging derived hypoxia for the risk stratification of prostate cancer in peripheral zone.
    Chen Z; Xue Y; Zhang Z; Li W; Wen M; Zhao Y; Li J; Weng Z; Ye Q
    Eur J Radiol; 2020 Apr; 125():108865. PubMed ID: 32058895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Inclusion of Apparent Diffusion Coefficients in Multiparametric Prostate MRI Structured Reports: Discrimination of Clinically Insignificant and Significant Cancers.
    Costa DN; Xi Y; Aziz M; Passoni N; Shakir N; Goldberg K; Francis F; Roehrborn CG; Leon AD; Pedrosa I
    AJR Am J Roentgenol; 2019 Jan; 212(1):109-116. PubMed ID: 30383404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI-measured adipose features as predictive factors for detection of prostate cancer in males undergoing systematic prostate biopsy: a retrospective study based on a Chinese population.
    Xiong T; Cao F; Zhu G; Ye X; Cui Y; Zhang H; Niu Y
    Adipocyte; 2022 Dec; 11(1):653-664. PubMed ID: 36415995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of
    Scheltema MJ; Chang JI; Stricker PD; van Leeuwen PJ; Nguyen QA; Ho B; Delprado W; Lee J; Thompson JE; Cusick T; Spriensma AS; Siriwardana AR; Yuen C; Kooner R; Hruby G; O'Neill G; Emmett L
    BJU Int; 2019 Nov; 124 Suppl 1():42-49. PubMed ID: 31287613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining Magnetic Resonance Diffusion-Weighted Imaging with Prostate-Specific Antigen to Differentiate Between Malignant and Benign Prostate Lesions.
    Han L; He G; Mei Y; Yu Q; Zhao M; Luo F; Cheng G; Liang W
    Med Sci Monit; 2022 Apr; 28():e935307. PubMed ID: 35459760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of mean apparent diffusion coefficient measured with diffusion-weighted magnetic resonance image in patients with prostate cancer treated with definitive radiotherapy.
    Onal C; Erbay G; Guler OC; Oymak E
    Radiother Oncol; 2022 Aug; 173():285-291. PubMed ID: 35753556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUVmax/ADC Ratio as a Molecular Imaging Biomarker for Diagnosis of Biopsy-Naïve Primary Prostate Cancer.
    Chinnappan S; Chandra P; Kumar JS; Chandran G; Nath S
    Indian J Nucl Med; 2021; 36(4):377-384. PubMed ID: 35125755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging radiomic features for recurrent prostate cancer following proton radiation therapy-A pilot study.
    Bazargani S; Feibus AH; Elshafei A; Al-Toubat M; Gopireddy DR; Gautam S; Barwari S; Henderson R; Lall C; Balaji KC; Bandyk M
    Urol Oncol; 2023 Mar; 41(3):145.e1-145.e5. PubMed ID: 36496342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of pathological upgrading in low-risk prostate cancer patients without hypointense lesions on an apparent diffusion coefficient map of multiparametric magnetic resonance imaging.
    Kang M; Song B; Lee I; Lee SE; Byun SS; Hong SK
    World J Urol; 2016 Nov; 34(11):1541-1546. PubMed ID: 27074937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
    Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
    BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.